Insmed Financials
| INSM Stock | USD 73.81 1.14 1.57% |
Insmed |
Understanding current and past Insmed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Insmed's financial statements are interrelated, with each one affecting the others. For example, an increase in Insmed's assets may result in an increase in income on the income statement.
Insmed Stock Summary
Insmed competes with Ascendis Pharma, Apellis Pharmaceuticals, BeiGene, Akero Therapeutics, and Blueprint Medicines. Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 613 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US4576693075 |
| CUSIP | 457669307 457669208 457669109 |
| Location | New Jersey; U.S.A |
| Business Address | 700 Highway 202206, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.insmed.com |
| Phone | 908 977 9900 |
| Currency | USD - US Dollar |
Insmed Key Financial Ratios
| Return On Equity | -8.91 | ||||
| Return On Asset | -0.26 | ||||
| Target Price | 88.87 | ||||
| Number Of Employees | 912 | ||||
| Beta | 1.12 |
Insmed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info.Insmed Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Insmed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Insmed Inc Systematic Risk
Insmed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Insmed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Insmed Inc correlated with the market. If Beta is less than 0 Insmed generally moves in the opposite direction as compared to the market. If Insmed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Insmed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Insmed is generally in the same direction as the market. If Beta > 1 Insmed moves generally in the same direction as, but more than the movement of the benchmark.
Insmed November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Insmed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Insmed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Insmed Inc based on widely used predictive technical indicators. In general, we focus on analyzing Insmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Insmed's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.46 | |||
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 12.11 | |||
| Value At Risk | (3.22) | |||
| Potential Upside | 2.88 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.